VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1684032
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Sore arm; This is a spontaneous report from a contactable consumer via a Pfizer sales representative. A male patient of an unspecified age (reported as Age: 66, unit: unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced sore arm after use of product on an unspecified date. The outcome of the event was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1684033
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Sore arm; This is a spontaneous report from contactable consumer (patient) via Pfizer Sales Representative. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date as a dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that, a patient of female 66 had a sore arm after the vaccine on an unspecified date. Stated that, the event took place after use of product. The outcome of the event was unknown. Information about batch/lot number has been requested. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1684034
Sex: M
Age:
State: NJ

Vax Date: 02/15/2021
Onset Date:
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: injection site pain; Arm pain; chilly; This is a spontaneous report from a contactable consumer. This consumer reported for a 65-year-old male patient (husband). A 65-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), dose 2 via an unspecified route of administration on 15Feb2021 as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced injection site pain, arm pain, chilly on an unspecified date. After the 1st dose, he had arm pain very quickly/right away. After 2nd dose- normal injection site pain only when go midway up and back and touching of injection site". "Arm pain on the same level". Caller says, "He definitely chilly". offered to warm transfer. Outcome of the event was unknown. Information about lot/Batch number has been requested. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1684035
Sex: F
Age:
State: MI

Vax Date: 02/23/2021
Onset Date:
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: sore throat; nausea; injection site redness; dermatofibroma/hardened area under skin; fatigue; confusion; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 81-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 02Feb2021 11:00 (Batch/Lot Number: EN9265) as dose 1, single, dose 2 via an unspecified route of administration, administered in Arm Right on 23Feb2021 14:00 (Batch/Lot Number: EN6200) as dose 2, single for covid-19 immunisation (age at vaccination 81 year old). Medical history included congenital heart failure, atrial fibrillation, essential tremor, Known Allergies: PCN, Tetracycline, Erythromycin, Rocephin, sulfa, codeine, ms, demerol from an unknown date and unknown if ongoing. Concomitant medication(s) included propranolol hydrochloride (INDERAL); atorvastatin (ATORVASTATIN); apixaban (ELIQUIS); montelukast sodium (SINGULAIR); duloxetine hydrochloride (CYMBALTA) taken for an unspecified indication, start and stop date were not reported. The patient previously took tetracycline and experienced Known Allergies: tetracycline, erythromycin and e Known allergies: Rocephin, rocephin [ceftriaxone] and experienced drug hypersensitivity, codeine and experienced drug hypersensitivity. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On unspecified date, the patient experienced sore throat, nausea, injection site redness, dermatofibroma/hardened area under skin, fatigue, confusion. Adverse event: sore throat, nausea, sore arm with reddened area at injection site (2 inches) with hardened area under skin, fatigue, occasional fogginess. No treatment was received. The outcomr for all events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: INDERAL; ATORVASTATIN; ELIQUIS; SINGULAIR; CYMBALTA

Current Illness:

ID: 1684036
Sex: F
Age:
State: NY

Vax Date: 02/22/2021
Onset Date: 02/24/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: I did experience with both doses, I had some swollen lymph node; having blood in her urine; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6201), via an unspecified route of administration on 22Feb2021 (at the age of 45-years-old) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number was not reported) on an unspecified date as dose 1, single for covid-19 immunisation, and experienced swollen lymph nodes. On 24Feb2021, the patient experienced having blood in her urine. On an unspecified date, she had some swollen lymph node. The outcome of blood in urine was not recovered; outcome of swollen lymph nodes was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1684037
Sex: M
Age:
State: IN

Vax Date: 02/17/2021
Onset Date: 02/20/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: frequent urination; diarrhea; chills; nausea; vomiting; loss of appetite; intermittent chest pain; This is a spontaneous report from a Pfizer sponsored Program. A contactable Consumer reported A 81-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 2 via an unspecified route of administration on 17Feb2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included sarcoidosis from an unknown date and unknown if ongoing. Took their 1st Pfizer vaccine dose on 23Jan2021 for covid immunisation. The patient's concomitant medications were not reported. on 20Feb2021 Caller states, starting on the 20Feb2021, her husband started having frequent urination, chills, diarrhea, nausea, vomiting, loss of appetite and intermittent chest pain. Outcome of the events was unknown No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1684038
Sex: F
Age:
State: FL

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: itching all over; This is a spontaneous report from a contactable Nurse (patient). An 82-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 18Feb2021 (Batch/Lot Number: EL9267; Expiration Date: May2021) (at the age of 82 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included an unspecified medicine. The patient experienced itching all over (reported as non-serious) on 18Feb2021 with outcome of not recovered. Patient took the COVID shot, the first dose, and she has been itching ever since. Patient thought it was something else at first, but then went off that medicine for three days and the itching was still just as bad as it was when she was on that medicine. The outcome of event was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1684039
Sex: F
Age:
State:

Vax Date: 02/23/2021
Onset Date:
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: mild rash on the front of her torso; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number and Expiration date were not reported), via an unspecified route of administration on 23Feb2021 as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced mild rash on the front of her torso on an unspecified date. The patient was asking if the side effect has been reported and if developing a rash after the second dose of the Pfizer COVID-19 vaccine would be a contraindication to any future booster shots created for variants strains that are created. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1684040
Sex: F
Age:
State: CT

Vax Date: 02/19/2021
Onset Date: 02/20/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Swollen arm; Nauseated; Headache; all over her joints; even her toes everything she said the pain is excruciating; intense body pain; unbelievable pain in arm/even her toes everything; This is a spontaneous report from a contactable consumer reporting for her mom. An 81-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 at the age of 81-years-old via an unspecified route of administration on 19Feb2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included macular degeneration from an unknown date. Concomitant medication included ascorbic acid, ergocalciferol, nicotinamide, retinol, riboflavin, thiamine hydrochloride (VITAMINS) taken for an unspecified indication, start and stop date were not reported and unspecified pills for macular. The reporter reported that they were calling regarding their mom (patient), she has had her second Pfizer shot yesterday, she felt fine afterwards as they held them there to monitor her, she actually felt fine up until she went to bed last night which was around 10 o'clock, but she woke up in the middle of the night on 20Feb2021 with unbelievable pain not only in her arm but all over her joints. The reporter checked her a little while ago and her arm is very swollen and she says she feels like she is very nauseated she has bad headache, and she said even her toes everything she said the pain is excruciating. They have got a little worse, she is feeling nausea, headache, intense body pain, she said every part of her body hurts and her arm is still very swollen. The outcome of the events was unknown. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: VITAMINS [ASCORBIC ACID;ERGOCALCIFEROL;NICOTINAMIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE]

Current Illness:

ID: 1684041
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Body wight; Result Unstructured Data: Test Result:170 or 165; Comments: probably 170 or165, something like that

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: some swollen lymph node; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications. The patient experienced some swollen lymph node on an unspecified date with outcome of unknown. The patient underwent lab tests and procedures which included weight: 170 or 165 (probably 170 or165, something like that). The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1684042
Sex: F
Age:
State: VA

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:normal; Test Name: Chest X-ray; Result Unstructured Data: Test Result:unknown results; Comments: She had a Chest X-ray two years

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: frightened about taking the second dose; worsened gastritis; doubled up on medication; severe chest pain on left side; Chills; left rib cage is killing her and around her kidney; has not been eating; This is a spontaneous report from a contactable consumer. A 73-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EN6200), via an unspecified route of administration, administrated in left arm on 24Feb2021 01:00 (age at the time of vaccination 73-years-old), as a single dose for COVID-19 immunization. The patient's medical history included breast cancer, she had breast cancer in 2014 or 2015, the nodes were removed, she was on an antibiotic when she had cancer, and surgeries. The patient's concomitant medication included Nexium 20mg daily for a hiatal hernia and acid reflux and it works. On 24Feb2021, the patient experienced worsened gastritis, doubled up on medication, severe chest pain on left side, Chills, left rib cage is killing her and around her kidney, has not been eating; and on an Unspecified date frightened about taking the second dose. On an unspecified date, the patient underwent lab tests and procedures which included Blood pressure measurement: normal; and Chest X-ray: unknown results, she had a Chest X-ray two years. The outcome for all the events was not recovered and frightened about taking the second dose was unknown. No follow attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1684043
Sex: F
Age:
State: CA

Vax Date: 02/11/2021
Onset Date: 02/21/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data: Test Date: 20210221; Test Name: BP; Result Unstructured Data: Test Result:high

Allergies:

Symptom List: Rash, Urticaria

Symptoms: nose bleeds mostly early morning (Am); dizziness; high BP; This is a spontaneous report from a contactable consumer received via COVID-19 Vaccine Adverse Event Reporting System . An 81-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number unknown), via an unspecified route of administration, administered in the right arm on 11Feb2021, at 14:30 (at the age of 81 years old) as dose 1, single for COVID-19 immunisation. Medical history included heart problem, hypertension, hypothyroidism, back pain, and known allergies: fish. She was not pregnant at the time of report. Concomitant medications included tramadol, lorazepam, atorvastatin calcium (LIPITOR), paracetamol (TYLENOL), and levothyroxine sodium (LEVOTHYROXIN). The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 21Feb2021, at 09:00, the patient experienced nose bleeds mostly early morning (Am), dizziness, and high BP. The patient was not diagnosed with COVID-19 prior to vaccination and she has not been tested for COVID-19 since the vaccination. No therapeutic measures were taken as a result of the events. The patient has not recovered from the events at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: TRAMADOL; LORAZEPAM; LIPITOR; TYLENOL; LEVOTHYROXIN

Current Illness:

ID: 1684044
Sex: F
Age:
State: SC

Vax Date: 02/13/2021
Onset Date: 02/13/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: She couldn't sleep it was terrible; Feeling unwell; Tiredness; mild headache; Muscle pain; Chills; really bad joint pain; The whole inside of her body felt hot; injection site pain; This is a spontaneous report from a contactable consumer (reported for herself). A 78-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: EN6200; expiration date on an unknown dated Jun2021), via an unspecified route of administration, administered in arm left on 13Feb2021 12:30 (age at vaccination was 78-year-old) as dose 1, single for covid-19 immunisation in medical building. No other vaccine was administered on the same day of Pfizer vaccine. Medical history included breast cancer, blood pressure, immune system is compromised from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included valsartan taken for blood pressure from an unspecified start date and ongoing (15 to 20 years); rosuvastatin (generic was for crestor) taken for an unspecified indication from an unspecified start date and ongoing (15 to 20 years), vitamin d3 taken for an unspecified indication from an unspecified start date and ongoing (20 years), zinc taken for an unspecified indication from unknown dated sep2020 and ongoing. She had her first dose of the vaccination on 13Feb2021. The patient was reported her experience. The patient stated that the symptoms after the first dose was injection site pain on 13Feb2021 night. On 15Feb2021, two days after the first dose the patient experienced every symptom tiredness (the patient stated it was extreme fatigue), mild headache (the patient head ached, but it was not severe pains like with a headache the patient head felt heavy and achy), chills, it was bad muscle and joint. Her whole body hurt and was very painful. It says fever, not had a thermometer. She felt hot. The whole inside of her body felt hot. Feeling unwell goes with all the other symptoms. All symptoms had resolved within 48 hours. The patient stated that she did not had nausea or swollen lymph nodes. The patient researched everything she could find and there was nothing about having these symptoms after the first dose. On an unknown date, the patient could not sleep it was terrible. The first night she didn't take anything. Laying down hurt a lot. She turned a lot to find a comfortable position. She had to take TYLENOL lot number COO3R7, expiry date: Jan2022 (acetaminophen) extra strength 500mg she only took one that second night and got some sleep that night. She woke up several times. When she woke up the following day, she was much better. It went away by the afternoon. The patient had not visited emergency room or physician office. The outcome of the event injection site pain was resolved on 14Feb2021. The outcome of the event feeling unwell was unknown. The outcome of the event she couldn't sleep it was terrible resolved on an unknown date 2021. The outcome for all other events was resolved on an unknown date 2021 (within 48 hours). No follow-up attempts are possible. No further information is expected.

Other Meds: VALSARTAN; ROSUVASTATIN; VITAMIN D3; ZINC

Current Illness:

ID: 1684045
Sex: F
Age:
State: IN

Vax Date: 02/02/2021
Onset Date: 02/08/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: ankle brachial index; Result Unstructured Data: Test Result:within normal limits

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: swelling and bruising of bilateral feet from toes to proximal ankle area; swelling and bruising of bilateral feet from toes to proximal ankle area; This is a spontaneous report from a contactable physician received via Pfizer study. A non-pregnant 87-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EN5318 and Expiration date: not reported) via an unspecified route of administration on 02Feb2021 (at the age of 87 years old) as dose 2, single for COVID-19 immunisation. The patient's medical history included HTN, GERD w/ duodenal ulcer, anemia, osteoporosis, and penicillin allergy. Concomitant medications included calcium carbonate;colecalciferol (CALCIUM +D), iron (IRON 325), furosemide (LASIX 20), and MVI for unspecified indications. The patient previously received the 1st dose of BNT162B2 (Lot number: EK9231) on 12Jan2021 (at the age of 86 years old) for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination nor was tested for COVID-19 since vaccination. On 08Feb2021, the patient experienced swelling and bruising of bilateral feet from toes to proximal ankle area. There was no pain, not hot nor cool to touch, normal pedal pulses and papillary refill, non blanchable, no fever or chills. On an unspecified date in 2021, an ankle brachial index testing was performed to rule out any circulatory impairment; the result was within normal limits. The patient came back to the physician's office on 26Feb2021 and, overall, swelling improved by 75% (left lateral foot/ankle swelling noted and minimal on right foot). Discoloration of blue cyanosis/bruising color was noted minimally on the 3rd digit of the left foot. The right foot still had blue cyanotic/bruised type discoloration at the base of 2nd-3rd-4th digits, extending proximally by 1 inch and approximately 1.5 inches laterally. The outcome of the reported events was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: CALCIUM +D [CALCIUM CARBONATE;COLECALCIFEROL]; IRON 325; LASIX 20 [FUROSEMIDE]

Current Illness:

ID: 1684046
Sex: F
Age:
State: NY

Vax Date: 02/17/2021
Onset Date: 02/21/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:ultra high blood pressure reading for one day

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: experienced dizziness; ultra high blood pressure reading for one day; headache; no appetite; flushing; weakness in legs; fatigue; malaise; This is a spontaneous report from a contactable consumer. This consumer (patient) reported that: A 81-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number were not reported), via an unspecified route of administration, administered in left arm on 17Feb2021 14:00 (at the age of 81-years-old) as Dose 2, SINGLE for COVID-19 immunization. The patient medical history had not reported. The patient had not any allergies. The patient was not pregnant at the time of vaccination. There were no concomitant medications. The patient had not received any other vaccine within four weeks prior to vaccination. The patient had not received any other medication within two weeks prior vaccination. The patient had not covid prior vaccination. The patient had not covid tested post vaccination. The patient had received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number were not reported), via an unspecified route of administration, administered in left arm on 27Jan2021 19:00 (at the age of 81-years-old) as Dose 1, SINGLE for COVID-19 immunization. On 21Feb2021 07:00 after the second dose of vaccination, the patient experienced dizziness, ultra-high blood pressure reading for one day, headache, no appetite, flushing, weakness in legs, fatigue and malaise. It was reported no side effects at all initially from either vaccination but after second shot on the 4th day after patient experienced dizziness, ultra-high blood pressure reading for one day, headache, no appetite, flushing but no fever, weakness in legs, fatigue, malaise...lasted 4 days and then reverted back to totally normal. On an unspecified date, the patient underwent lab tests and procedures which included blood pressure measurement: ultra-high blood pressure reading for one day. The patient had not received any treatment for the adverse events. The outcome of events was recovered on an unspecified date. Information about Lot/batch number has been requested. Follow-up (12May2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1684047
Sex: M
Age:
State:

Vax Date: 02/25/2021
Onset Date: 02/01/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: eyes are swollen; This is a spontaneous report from a contactable health care professional (patient's son). A male patient of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on 25Feb2021 (lot number was not reported) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient has no trouble breathing but his eyes are swollen on an unknown date in Feb2021. The reporter wanted to know if this could be an allergic reaction and what medication the patient can take for it. The outcome of the event was unknown. The lot number for BNT161B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1684048
Sex: F
Age:
State: NC

Vax Date:
Onset Date:
Rec V Date: 09/08/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: bad flair up of her Hidradenitis Suppurativa; This is a spontaneous report from a contactable physician. A 47-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 2 via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. Medical history included Hidrandenitis Suppurativa, rheumatoid arthritis, Inflammatory bowel, autoimmune issues, Flares. The patient's concomitant medications were not reported. The patient previously took dose 1 BNT162B2 for COVID-19 immunization. The patient experienced 2 days later bad flair up of her hidradenitis suppurativa (condition aggravated) on an unspecified date. Reporter stated, Strong family history of this Hidrandenititis Suppurativa. She flares once a Month, it was temporary, but pretty bad, on the buttocks. Would it be a Flare up caused by the vaccine? The inflammatory reaction looks like a boil, not necessarily with any bacteria. In the long run chronic condition, you end up with sinus tracks. It hasn't formed a pus pocket. Reporter didn't have much of a reaction from the vaccine, either, and was assuming I am safe. reporter have taken the HEP B vaccine and have never had any antibodies after these shots. Patient received treatment of steroids. The outcome of event was unknown. No follow up attempts are needed. Information on Lot/batch cannot be requested. No further information is expected.

Other Meds:

Current Illness:

ID: 1684049
Sex: M
Age:
State:

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: I blew my nose and a ton of blood came out; when the administrator removed the needle from his arm, he saw a small amount/stream of liquid squirt in the trash can; This is a spontaneous report received from a contactable consumer (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/lot number and expiration date were not reported), via an unspecified route of administration on 24Feb2021 as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 24Feb2021, when the administrator removed the needle from the patient's arm, he saw a small amount/stream of liquid squirt in the trash can. The reporter queried if this means that he did not receive the full dose amount and if he should repeat the dose. On the night of 24Feb2021, the patient experienced he blew his nose and a ton of blood came out and it didn't stop for a few hours. The outcome of the event blew his nose and a ton of blood came out and it didn't stop for a few hours was not recovered; the event has been ongoing, off and on. The reporter stated he did not know if that was related to the vaccine or not and asked if he should tell his doctor. The reporter was querying regarding the third dose of the Pfizer Covid-19 vaccine. Patient was also querying if he gets the 2nd dose (of the Pfizer Covid-19 vaccine), will the side effects be worse and if so, why are they worse. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1684050
Sex: F
Age:
State:

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: light headedness; migrating sensation of tingling over the body and the face; coldness of feet, and hands with decreased perfusions; coldness of feet, and hands with decreased perfusions; upper gums, eyelids, and nose became extremely cold; bowel urgency; This is a spontaneous report from a non-contactable other hcp. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number, and Expiration date were not reported), via an unspecified route of administration on 22Feb2021, as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced light headedness, migrating sensation of tingling over the body and the face, coldness of feet, and hands with decreased perfusions, upper gums, eyelids, and nose became extremely cold, and bowel urgency on 22Feb2021. It was reported that patient had an immediate post vaccination onset of intermittent light headedness, and migrating sensation of tingling over the body and the face. After 45 minutes, patient also experienced a sequence of coldness of feet, and hands with decreased perfusions. As those resolved, the core/trunk warmed. Then 75 minutes post injection, patient's upper gums, eyelids, and nose became extremely cold. Patient also had bowel urgency. After 2 hours, HCP said that the patient had a warm flush sensation, clearer mind, better color vision, and was feeling stronger. She said the lightheadedness resolved within 3 hours with Pharmacist's supervision. No urticaria, angioedema, or respiratory distress was observed. No treatment was done as patient could still stand and walk with assistance. HCP said patient just rested at home. However, HCP said there was a representation of light headedness and tingling sensation on 22Feb, and mildly on 24Feb while patient was resting. HCP wanted to know if the 2nd dose would be contraindicated to the patient based on her reaction to the 1st dose. She also wanted to know what are the other side effects that they should watch out for, and if Pfizer would classify these side effects as an allergic reaction. The outcome of events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1684051
Sex: M
Age:
State: NM

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: dizziness; hand is getting numb; feeling hot all over; Grabbed at chest "it feels a little tight"; This is a spontaneous report from a contactable pharmacist. A 30-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL3302, Expiration date was not reported), dose 2 intramuscular, administered in Arm Left on 14Jan2021 11:30 (age at vaccination 30 years) as dose 2, single for covid-19 immunisation. Medical history included none. There were no concomitant medications. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL1284, Expiration date was not reported), dose 1 intramuscular, administered in Arm Left on 23Dec2020 01:15 as dose 1, single for covid-19 immunisation and experienced 1155 c/o headache. The patient previously took azithromycin, ibuprofen experienced drug hypersensitivity (unknown reaction). Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. on 14Jan2021 11:45 the patient experienced dizziness, hand is getting numb, feeling hot all over, grabbed at chest it feels a little tight. The patient visited emergency room for reported events. The patient experienced Took pt to adult urgent care in wheelchair. Patient was seen in urgent care and referred to ED at 12:50pm. The patient did not receive any treatment for reported for events. On an unspecified date in 2021, the patient had recovered from the events. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1684052
Sex: M
Age:
State:

Vax Date: 02/12/2021
Onset Date: 02/01/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: sore throat; cough; weakness; This is a spontaneous report from a non-contactable consumer received via the Medical Information Team. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, on 12Feb2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced sore throat, cough, and weakness on an unspecified date in Feb2021. The consumer wanted to know if the second dose of vaccine administration could be delayed for medical reasons, since the patient was experiencing side effects from the first dose. The patient did not recover from the events on the time of the report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1684053
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: ALT; Result Unstructured Data: Test Result:are in the 600's range; Test Name: AST; Result Unstructured Data: Test Result:are in the 600's range; Test Name: Liver Biopsy; Result Unstructured Data: Test Result:Unknown Results; Test Name: extensive testing; Result Unstructured Data: Test Result:Unknown Results

Allergies:

Symptom List: Unevaluable event

Symptoms: abnormal liver values / liver enzymes, ALT and AST specifically, are in the 600's range. Her Hepatologist believes that these levels are drug induced; abnormal liver values / liver enzymes, ALT and AST specifically, are in the 600's range. Her Hepatologist believes that these levels are drug induced; This is a spontaneous report from a contactable physician. A 74-year-old female patient received first dose of BNT162B2 (BNT162B2) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE, and second dose via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced abnormal liver values / liver enzymes, ALT and AST specifically, are in the 600's range. her hepatologist believes that these levels are drug induced on unspecified date. The physician states that a 74 year old female has received both doses of the Pfizer COVID-19 vaccine and her liver enzymes, ALT and AST specifically, are in the 600's range. Her Hepatologist believes that these levels are drug induced. The patient has had extensive testing and a liver biopsy as well. The patient has not reported this AE yet to Drug Safety at Pfizer. The patient underwent lab tests and procedures which included ALT (alanine aminotransferase) and AST (aspartate aminotransferase): are in the 600's range on an unspecified date and Liver Biopsy (biopsy liver): unknown results on an unspecified date and extensive testing (investigation): unknown results on an unspecified date. Outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot been obtained; Sender's Comments: based on the available information the causal relation ship between the suspect vaccine BNT162B2 and thnte adverse event ALT (alanine aminotransferase) and AST (aspartate aminotransferase) increased cannot be totally ruled out The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate

Other Meds:

Current Illness:

ID: 1684054
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: itching of skin; bilateral hand numbness; Differential Diagnosis: Systemic reaction (hypoglycemia, hypotension, generalized rash); Differential Diagnosis: Systemic reaction (hypoglycemia, hypotension, generalized rash); Differential Diagnosis: Systemic reaction (hypoglycemia, hypotension, generalized rash); This is a spontaneous report from a non-contactable other hcp. A 34-year-old female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: EN6205), via an unspecified route of administration on an unspecified date (at the age of 34-years-old) as dose 1, single for COVID-19 immunisation. The medical history and concomitant medications of the patient were not reported. It was reported during her 15-minute waiting period after the injection, the patient experienced itching of skin, bilateral hand numbness, differential diagnosis: systemic reaction (hypoglycemia, hypotension, generalized rash) on an unspecified date. The patient was stable to go home and follow up with PCP. Therapeutic measures were taken as a result of events that included antihistamines and water initially with zyrtec, she was not seeing improvement. Two doses of 25 mg of benadryl of 15 minutes within each other, pt was able to see improvement. Pt aware of when she is able to take more benadryl if needed. If symptoms worsen or do not respond to benadryl, pt aware to go to ED. The follow up response to treatment was reported as good. The outcome of the events was reported as unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1684055
Sex: F
Age:
State: LA

Vax Date: 02/24/2021
Onset Date: 02/26/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: feeling itchy on her back and legs, experiencing a lot of itching, her skin is itching; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 24Feb2021 (Batch/Lot Number: EN6200) (at the age of 62 years) as DOSE 1, SINGLE for covid-19 immunisation. Medical history was none. There were no concomitant medications. The patient experienced feeling itchy on her back and legs, experiencing a lot of itching, her skin is itching on 26Feb2021 with outcome of not recovered. No follow-up attempts are possible. No further information expected.

Other Meds:

Current Illness:

ID: 1684056
Sex: F
Age:
State: GA

Vax Date: 02/04/2021
Onset Date: 02/05/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: extreme pain/mild soreness; muscle spasm; nerve pain in my right arm into my neck; This is a spontaneous report from a contactable pharmacist. A adult female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 2 via an unspecified route of administration on 04Feb2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient took historical vaccine (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 product COVID 19, lot unknown False, for covid 19 immunisation. On 05Feb2021 the day after receiving the second dose of my Pfizer COVID vaccine, patient began having extreme pain and muscle spasm/nerve pain in my right arm (where patient got my injection) into her neck. The pain was only resolved after IM Toradol and PO cyclobenzaprine. Patient still have some mild soreness in these areas. Pain was 10 out of 10 - worst pain ever experienced. There is no seriousness criteria such as Results in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect. Prior to vaccination, was the patient diagnosed with COVID-19 was Unknown Since the vaccination, has the patient been tested for COVID-19 also unknown. Therapeutic measures were taken as a result of extreme pain/mild soreness (pain), muscle spasm (muscle spasms), nerve pain in my right arm into my neck (neuralgia). Outcome of the events was unknown. Information on the lot/batch number has been requested Follow-up attempts completed. No further information expected

Other Meds:

Current Illness:

ID: 1684057
Sex: F
Age:
State: GA

Vax Date: 01/26/2021
Onset Date:
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: She experienced consistent rash all over body that involved itching. Rash blotches were on her neck, legs, and arm.; This is a spontaneous report from a contactable pharmacist received via regulatory authority portal. An adult female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 26Jan2021 (Batch/Lot Number: EL8982; Expiration Date: 31May2021) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot Number not reported) on 05Jan2021 for COVID-19 immunisation. The patient experienced consistent rash all over body that involved itching, rash blotches were on her neck, legs, and arm on an unspecified date in 2021. The rash at times would disappear from one area and appear in another. It would also appear in multiple sites at once. As of Wednesday, 10Feb2021, rash was still present. The patient did not experience the event with the first dose. The outcome of event was not recovered. The adverse event resulted in none. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1684058
Sex: F
Age:
State: IN

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Quarter size raised red circle; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the right arm on 22Feb2021 at 11:45 (at the age of 68-years-old) (Lot Number: 6201) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at the time of the events. The patient has known allergies. The patient did not receive other vaccine in four weeks. The patient did not have COVID prior to vaccination and had not been tested for COVID post-vaccination. On 22Feb2021 at 12:00, the patient experienced quarter size raised red circle where the shot was given. It was reported that it does not hurt and has not gone away after 4 days. No treatment was received for the event. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1684059
Sex: M
Age:
State: FL

Vax Date: 02/24/2021
Onset Date: 02/26/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Rash developed on both forearms from wrists to elbows; This is a spontaneous report from a contactable healthcare professional (patient). A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: EN6200, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 24Feb2021 at 16:00 (at the age of 52-years-old) as dose 1, single for COVID-19 immunisation. Medical history included high blood pressure and gastroesophageal reflux disease (GERD). The patient has no known allergies. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to vaccination, the patient has not been diagnosed with COVID-19. Concomitant medications included lisinopril, acetylsalicylic acid (ASPIRIN), ibuprofen, multivitamins and P. The patient experienced rash developed on both forearms from wrists to elbows on 26Feb2021 at 12:00. The event occurred approximately two days after receiving the vaccine. Nothing abnormal at injection site and no other rashes seen. No treatment was received for the event. Since the vaccination the patient has not been tested for COVID-19. The outcome of the event was not recovered. No follow-up attempts are possible. No further information expected.

Other Meds: LISINOPRIL; ASPIRIN [ACETYLSALICYLIC ACID]; IBUPROFEN

Current Illness:

ID: 1684060
Sex: F
Age:
State: MA

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210221; Test Name: Nasal swab; Test Result: Negative

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: cannot walk or exercise; cannot sit/cannot walk or exercise; I had arthritis before the shots, but this pain is worse than I have ever felt; can't sleep; This is a spontaneous report from a contactable consumer. A non-pregnant 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 14Jan2021 10:00 (Batch/Lot Number: EL3249) as dose 1, single (at the age o 42 years old) for COVID-19 immunisation. Medical history included ongoing arthritis before the shots. No known allergies. The patient's concomitant medications were not reported. The patient stated, "I had arthritis before the shots, but this pain is worse than I have ever felt. I cannot sleep. I cannot sit. I cannot walk or exercise". AE treatment: Cortisone shot for hip. Covid test type post vaccination: Nasal Swab on 21Feb2021 and the result is negative. The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness: Arthritis (arthritis before the shots.)

ID: 1684061
Sex: F
Age:
State: CO

Vax Date: 02/16/2021
Onset Date: 02/23/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: prickly pimply rash; This is a spontaneous report from a contactable consumer (patient) received via COVAES. A non-pregnant 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EN9581 and Expiration date: not reported) via an unspecified route of administration, administered on the right arm on 16Feb2021 17:45 (at the age of 59 years old) as dose 1, single for COVID-19 immunisation. The vaccine was administered in a Public Health Clinic. The patient's medical history included high blood pressure, atrial flutter, shingles in 2015, Zika virus in 2016, and sulfa allergy. Concomitant medications included amlodipine besilate;benazepril hydrochloride (AMLODIPINE/BENAZEPRIL), metoprolol, and acetylsalicylic acid (BABY ASPIRIN) taken for unspecified indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination nor was tested for COVID-19 since vaccination. On 23Feb2021 18:00, the patient started getting a prickly pimply rash on the lower back. Since then, it started spreading around the upper arms, legs, torso, and neck. On 27Feb2021, it was reported that the rash was pretty much everywhere. The patient also reported that she experienced a similar rash when she had the Zika virus and shingles. The patient used diphenhydramine hydrochloride (BENADRYL) as treatment but reported that the rash seemed to be getting worse than better. The outcome of the reported event was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: AMLODIPINE/BENAZEPRIL; METOPROLOL; BABY ASPIRIN

Current Illness:

ID: 1684062
Sex: F
Age:
State: TX

Vax Date: 02/20/2021
Onset Date:
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: sore arm after the vaccine on the injection site; This is a spontaneous report from Pfizer-via Regulatory Authority Support from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on 20Feb2021 as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced sore arm after the vaccine on the injection site on an unspecified date. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1684063
Sex: F
Age:
State: PA

Vax Date: 02/12/2021
Onset Date: 02/13/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210213; Test Name: Body temperature; Result Unstructured Data: Test Result:100 degrees; Comments: unit: unspecified fever time: 01:00 PM

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: slight arm soreness; head ache; fever (100 degrees); This is a spontaneous report from a contactable other healthcare professional (patient). A 19-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/lot number: EI3302; Expiration date was not reported), via an unspecified route of administration in the left arm on 12Feb2021 04:45 PM (at the age of 19-years-old) as dose 1, single for COVID-19 immunisation at a workplace clinic. The patient's medical history was not reported. The patient has no concomitant medications. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. The patient experienced slight arm soreness, head ache and fever (100 degrees; unit: unspecified) on 13Feb2021 01:00 PM. No treatment was received for the events. The outcome of the events was recovered on 14Feb2021.

Other Meds:

Current Illness:

ID: 1684064
Sex: F
Age:
State: NC

Vax Date: 02/26/2021
Onset Date: 02/28/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Rash on chest, stomach and entire back.; This is a spontaneous report from a contactable other hcp (patient). A non-pregnant 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number, and Expiration date were not reported), via an unspecified route of administration, administered in the right arm on 26Feb2021 07:00 (at the age of 48-years-old), as dose 1, single for COVID-19 immunisation. Medical history included hypothyroidism. Concomitant medication included levothyroxine sodium (LEVOXYL) taken for an unspecified indication, start and stop date were not reported. The patient previously took cefalexin (KEFLEX) and experienced drug hypersensitivity. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced rash on chest, stomach and entire back on 28Feb2021 03:00. No treatment was received as a result of the event. The event also did not result to either emergency room or physician office visit. The outcome of event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LEVOXYL

Current Illness:

ID: 1684065
Sex: F
Age:
State: NJ

Vax Date: 02/15/2021
Onset Date: 02/16/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Round blister shallow crates mildly erythematous about 2xm; Round blister shallow crates mildly erythematous about 2xm; This is a spontaneous report from a contactable consumer. A 90-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the left arm on 15Feb2021 at 14:00 (at the age of 90-years-old) (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. Medical history included high blood pressure, heart valves, pre atrial contractions, and atrial fibrillation. The patient was not pregnant at the time of the events. The patient has no known allergies. Concomitant medications included metoprolol succinate (TOPROL), ranolazine (RANEXA), paracetamol (TYLENOL), metoprolol tartrate (LOPRESSOR) and calcium (CALCIUM). The patient did not receive other vaccines in four weeks. Toprol, Ranexa, Tylenol, Lopressor, and calcium were received in two weeks. The patient did not have COVID prior to vaccination and had not been tested for COVID post-vaccination. On 16Feb2021, the patient experienced round blister shallow crates mildly erythematous about 2xm. No treatment was received for the events. The outcome of the events was not recovered/not resolved. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: TOPROL; RANEXA; TYLENOL; LOPRESSOR; CALCIUM

Current Illness:

ID: 1684066
Sex: F
Age:
State: NJ

Vax Date: 02/26/2021
Onset Date: 02/27/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Itching all over body; nausea; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EN6198), via an unspecified route of administration, administered in the left arm on 26Feb2021, at 10:45 (at the age of 70 years old) as dose 1, single for COVID-19 immunisation. Medical history included pacemaker, SVT, and known allergies. The patient was not pregnant, and she was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included heart meds, vitamins, and diphenhydramine hydrochloride (BENADRYL). She did not receive any other vaccines within four weeks prior to the COVID vaccine. On 27Feb2021, the patient experienced itching all over body and nausea. She has not been tested for COVID-19 since the vaccination. No therapeutic measures were taken as a result of itching all over body and nausea. The patient was recovering from the events at the time of report. No follow-up attempts are possible. No further information is expected.

Other Meds: BENADRYL

Current Illness:

ID: 1684067
Sex: F
Age:
State: OH

Vax Date: 02/12/2021
Onset Date: 02/13/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: very itchy rash; This is a spontaneous report from a contactable consumer (patient) received. A non-pregnant 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EL9267 and Expiration date: not reported) via an unspecified route of administration, administered on the left arm on 12Feb2021 14:00 (at the age of 45 years old) as dose 1, single for COVID-19 immunisation. The patient's medical history included depression. The patient had no known allergies. Concomitant medications included fluoxetine hydrochloride (PROZAC), calcium, ashwagandha, cyanocobalamin (B12), and ascorbic acid;betacarotene;biotin;calcium;chromium;colecalciferol;copper;folic acid;iodine;iron;lycopene;magnesium;manganese;nicotinamide;pantothenic acid;phosphorus;phytomenadione;potassium;pyridoxine hydrochloride;retinol;riboflavin;selenium;vitamin b1 nos;vitamin b12 nos;vitamin e nos;xantofyl;zinc (CENTRUM SILVER) taken for unspecified indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination nor was tested for COVID-19 since vaccination. On 13Feb2021, the patient developed a very itchy rash. The rash started on the arm where the injection was and spread under the arm into the armpit area, around the chest area, and onto the other upper arm and armpit area. The patient used hydrocortisone (CORTIZONE, cream) and calamine as treatment. The patient recovered from the event on an unspecified date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds: PROZAC; CALCIUM; ASHWAGANDHA; B12 [CYANOCOBALAMIN]; CENTRUM SILVER [ASCORBIC ACID;BETACAROTENE;BIOTIN;CALCIUM;CHROMIUM;COLECALCIFEROL;COPPER;FOLIC ACID.

Current Illness:

ID: 1684068
Sex: M
Age:
State: CT

Vax Date: 02/19/2021
Onset Date: 02/20/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: phlegm had blood within; This is a spontaneous report from a contactable consumer (patient) via Pfizer sales representative. A 68-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and expiration date were not reported), via an unspecified route of administration on 19Feb2021 10:15 AM (at the age of 67-years-old) as dose 1, single for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medication included acetylsalicylic acid (ASPIRIN) taken for an unspecified indication; start and stop dates were not reported. The patient previously took clarithromycin (KETEK) and experienced allergy. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. The patient experienced phlegm had blood within on 20Feb2021 08:00AM, the morning after first vaccine. No treatment was taken for the events. The outcome of the event was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 1684069
Sex: F
Age:
State:

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210227; Test Name: Fever; Result Unstructured Data: Test Result:99.4; Comments: fever of 99.4.

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: body aches; headache; fever; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age (Age: 51, Unit: Unknown) received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), dose 1 via an unspecified route of administration on 27Feb2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter's wife received first dose of vaccine yesterday, 27Feb2021 and last night she started having body aches, she still have now body aches and a strong headache and she has a bit of a fever 99.4 (unit unknown). Patient was experiencing the following symptoms today (28Feb2021): headache, having body aches, fever of 99.4. Reporter would like to know if it is okay for his wife to take Tylenol. The outcome of the events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1684070
Sex: F
Age:
State: IL

Vax Date: 02/09/2021
Onset Date: 02/16/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Started with little red bumps that itched; lower right arm had a rash from elbow to wrist; This is a spontaneous report from a contactable consumer (patient) received via a regulatory authority. A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection),via an unspecified route of administration, administered in right arm on 09Feb2021 at 10:30 (Batch/Lot Number: EM9810) (at the age of 69-years-old) as dose 1, single for COVID-19 immunisation. Medical history included diabetic and known allergies to Penicillin, Sulfa and Codeine. The patient was not pregnant at time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. Concomitant medications included atorvastatin; glipizide; insulin degludec (TRESIBA) and Vitamin D; all taken for an unspecified indication, start and stop dates were not reported. The patient did not receive any other vaccines within 4 weeks prior to COVID-19 vaccine. The patient experienced started with little red bumps that itched then lower right arm had a rash from elbow to wrist on 16Feb2021 at 09:00. The patient received no treatment for the events. The outcome of events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: ATORVASTATIN; GLIPIZIDE; TRESIBA; VITAMIN D NOS

Current Illness:

ID: 1684071
Sex: F
Age:
State: GA

Vax Date: 02/26/2021
Onset Date: 02/27/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Achy; Feverish; Joint pain; This is a spontaneous report from a contactable consumer (patient). A 67-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: EL 9267, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 26Feb2021 at 15:30 (at the age of 67-years-old) as dose 1, single for COVID-19 immunisation. Medical history included COVID-19 from an unknown date. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. The patient's concomitant medications were not reported. On 27Feb2021 at 16:45, the patient experienced achy, feverish, and joint pain. No treatment was received for the events. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was recovering. No follow-up attempts are possible. No further information expected.

Other Meds:

Current Illness:

ID: 1684072
Sex: M
Age:
State: FL

Vax Date: 02/15/2021
Onset Date: 02/25/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: itchiness on the body; rash; This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number: 9262), via an unspecified route of administration in right arm on 15Feb2021 at 12:00, age at vaccination was 69-year-old, as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and post vaccination, the patient has not been tested for COVID-19. The patient's historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EL9262) via an unspecified route of administration in right arm on 24Jan2021 at 12:00 as dose 1, single for COVID-19 immunization. On 25Feb2021, the patient experienced itchiness on the body and rash. No therapeutic measures were taken as a result of the events. Outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1684073
Sex: F
Age:
State: CA

Vax Date: 02/19/2021
Onset Date: 02/26/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Itching and rash; Itching and rash; This is a spontaneous report from a contactable consumer (patient). An 81-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EM9809), via an unspecified route of administration, administered in arm left on 19Feb2021 12:00 (at the age of 81-years-old) as dose 1, single for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The vaccine was administered at the clinic. The patient had no known medical history. There were no concomitant medications. On 26Feb2021 12:00, the patient experienced itching and rash. No treatment was received for the events. The outcome of the events was not recovered. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1684074
Sex: F
Age:
State: TX

Vax Date: 02/24/2021
Onset Date: 02/25/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Bruising on my arm and soreness.; Mild headache; Bruising on my arm and soreness.; This is a spontaneous report from a contactable other healthcare professional (patient). A 25-year-old non-pregnant female patient received bnt162b2 (BNT162B2, Lot Number: EN6500), dose 1 via an unspecified route of administration, administered in left arm on 24Feb2021 18:45 (at the age of 25-year-old) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. No other vaccine in four weeks. On 25Feb2021 at 07:00, the patient experienced bruising on her arm and soreness and mild headache the day after injection. No Covid prior vaccination nor tested with Covid post vaccination. The patient received no treatment for the events. The patient recovered from the events on unspecified date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1684075
Sex: M
Age:
State:

Vax Date: 02/27/2021
Onset Date:
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: he "doesn't feel well"; feeling flushed; This is a spontaneous report from a Pfizer sponsored programs and regulatory authority Support. A contactable consumer (patient) reported that a 74-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 27Feb2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient received first dose of BNT162B2 for COVID-19 immunisation on an unspecified date. The patient's medical history was not reported. Concomitant medication included paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported. It was reported that the patient "doesn't feel well" and is "feeling flushed". He explained he took a Tylenol and asked if it is ok to take such medication post vaccination. The outcome of the events was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds: TYLENOL

Current Illness:

ID: 1684076
Sex: M
Age:
State: AZ

Vax Date: 02/05/2021
Onset Date: 02/01/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: rash on legs; This is a spontaneous report from a contactable consumer (patient) received via Pfizer study. An 84-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in right arm, on 05Feb2021 at 01:00 PM (Batch/Lot Number: EL342Z) (at the age of 83 years old) as dose 1, single for COVID-19 immunisation. Medical history included diabetic and chronic obstructive pulmonary disease (COPD). The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient has no known allergies. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced rash on legs on an unspecified date in Feb2021 after receiving the first dose. The patient was administered the second dose of BNT162B2 on 26Feb2021, single (at the age of 84-years-old) (Batch/Lot Number: EN62NZ) in the right arm for COVID-19 immunisation and experienced rash on the arm and rash on the legs on 26Feb2021. The patient has not taken any treatment for the event. The patient did not recover from the event on the time of the report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1684077
Sex: F
Age:
State: KY

Vax Date: 02/26/2021
Onset Date: 02/27/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210227; Test Name: Fever; Result Unstructured Data: Test Result:99.9

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Sore arm; sore neck; sore back; sore muscles; Fever of 99.9; This is a spontaneous report from a contactable healthcare professional (patient). A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), intramuscularly, administered in left arm, on 26Feb2021 at 02:45 PM (Batch/Lot Number: EN6198) (at the age of 57 years old) as dose 1, single for COVID-19 immunisation. Medical history included hypothyroidism, high blood pressure, and COVID-19. The patient has no known allergies. The patient was not pregnant at the time of vaccination. The patient was concomitantly taking unspecified medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced sore arm, sore neck, sore back and muscles and fever of 99.9 on 27Feb2021 at 06:00 AM. The patient underwent lab tests and procedures which included fever: 99.9, on 27Feb2021. The patient has not been tested for COVID-19 since the vaccination. The patient has not taken any treatment for the events. The patient did not recover from the events on the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1684078
Sex: F
Age:
State: OH

Vax Date: 02/22/2021
Onset Date: 02/01/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: getting pain in hip; became very, very painful; very bad lower back pain; She could hardly walk; This is a spontaneous report from a contactable consumer. An 83-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Feb2021 (Lot Number: EN6200) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. Medical history included Alzheimer's from an unknown date. The patient's concomitant medications were not reported. The reporter (patient's husband) stated, "I am calling about the Pfizer's COVID shot. About six hours after she received the shot yesterday, there are a couple of things. She is 83. She has Alzheimer's. She received the shot yesterday, about six hours later she started getting this pain in her hip. And it became very, very painful. And I am just wondering if that could be from the shot?" The patient got very bad lower back pain. She could hardly walk. Events occurred in Feb2021. The outcome of events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1684079
Sex: F
Age:
State: CA

Vax Date: 02/26/2021
Onset Date: 02/28/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Tongue swelled up; Tongue was burning; This is a spontaneous report from a contactable pharmacist (patient). A non-pregnant 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 26Feb2021 at 21:00 (Lot Number: En6205, unknown expiration; at the age of 35 years old) as dose 1, single for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication included escitalopram. No known allergies. No other vaccine in four weeks. The patient's tongue was burning, and tongue swelled up on 28Feb2021 at 10:00 am. The patient did not receive treatment for the events. The patient has no COVID prior vaccination and has not been tested for COVID post vaccination. The patient is recovering from the events. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: ESCITALOPRAM

Current Illness:

ID: 1684080
Sex: F
Age:
State: NM

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: blood pressure is extremely high; This is a spontaneous report from a contactable consumer (patient). A 44-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported) via an unspecified route of administration in left arm on 20Jan2021 12:00 as dose 1 and dose 2 on 02Feb2021 12:00 (Batch/Lot number was not reported) as single for COVID-19 immunization (at the age of 44-year-old, non-pregnant). Medical history included hypothyroidism and family history included hypertension, patients mother and sister also had the same after receiving the vaccine XX. Patient had no known allergies. Concomitant medication(s) (in two weeks) included levothyroxine and atorvastatin calcium (LIPITOR). Patient did not receive any other vaccine in four weeks. Patient had no COVID prior vaccination and COVID was not tested post vaccination. The patient experienced blood pressure was extremely high on 20Jan2021. AE resulted in doctor or other healthcare professional office/clinic visit. Patient received treatment with an unspecified medication for the event. The outcome of the event was not recovered. Information about lot/batch number has been requested. Follow-up attempts completed. No further information expected.

Other Meds: LEVOTHYROXINE; LIPITOR

Current Illness:

ID: 1684081
Sex: M
Age:
State: MI

Vax Date: 02/20/2021
Onset Date:
Rec V Date: 09/08/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Headache; Will that cause your eye, your eyes could turn color, it's sort of red, it's reddish/ My eyes are all of sudden red; This is a spontaneous report from a contactable consumer (patient). An 85-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration on 20Feb2021 (Batch/Lot Number: EL9261) as dose 2, single (at the age of 85-years-old) for Covid-19 immunisation. Medical history included blood pressure abnormal. Concomitant medication included blood pressure pills. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration in Jan2021 (Batch/Lot Number: unknown) as dose 1, single for Covid-19 immunisation. The patient had his second shot on last Saturday (20Feb2021), and the only effect he was feeling was headache on an unspecified date, which he knew he was going to get. The patient then asked if the vaccine would cause the eye to turn color, it was sort of red, it was reddish, and asked if that would be a side effect. The patient had the first dose three weeks prior (Jan2021). Regarding the treatment in response to the event, the patient stated no, he wears glasses but (incomplete sentence). The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am